Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: A link to protection against atherosclerosis?

To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in...

Full description

Saved in:
Bibliographic Details
Published inClinical biochemistry Vol. 42; no. 9; pp. 791 - 795
Main Authors Tapan, Serkan, Dogru, Teoman, Tasci, Ilker, Ercin, Cemal Nuri, Ozgurtas, Taner, Erbil, Mehmet Kemal
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2009
Subjects
Online AccessGet full text
ISSN0009-9120
1873-2933
1873-2933
DOI10.1016/j.clinbiochem.2009.02.005

Cover

More Information
Summary:To investigate the role of CD40 ligand and P-selectin in the mechanism of decreased incidence of cardiovascular disease in Gilbert's syndrome (GS). The soluble forms of CD40 ligand (sCD40L) and P-selectin (sP-selectin), and high sensitive C reactive protein (hs-CRP) levels were investigated in subjects with GS ( n = 25) and compared to healthy controls ( n = 53). sCD40L and hs-CRP levels were significantly lower in GS compared to the controls (0.33 ± 0.27 vs 0.71 ± 0.37 ng/mL, p < 0.001 and 0.51 ± 0.45 vs 1.16 ± 1.31 mg/L, p = 0.046, respectively). Both sCD40L and hs-CRP were negatively correlated with total bilirubin ( r = − 0.5, p < 0.001 and r = − 0.34, p = 0.002, respectively). sP-selectin levels were lower in GS when compared to the controls but the difference did not reach statistical significance ( p = 0.052). No correlation was found between the plasma levels of sCD40L, sP-selectin and hs-CRP. These novel findings suggest that reduced sCD40L and hs-CRP concentrations may have a role in the mechanism of protection against atherosclerosis in GS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0009-9120
1873-2933
1873-2933
DOI:10.1016/j.clinbiochem.2009.02.005